EBV-encoded proteins, such as latent membrane protein 1 (LMP1), can activate several oncogenic signaling pathways, including NF-κB and PI3K/AKT, which drive B-cell proliferation, promote genomic instability, and contribute to tumor progression (18). Here, NFKB1 is linked to neoplasm.